ScholarIQanswers from OpenAlex

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

PaperCitations, authors & open-access status

Trial of Anifrolumab in Active Systemic Lupus Erythematosus is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Trial of Anifrolumab in Active Systemic Lupus Erythematosus have?

ScholarIQcitation count

Trial of Anifrolumab in Active Systemic Lupus Erythematosus has 1,357 citations in the OpenAlex counts ScholarIQ stores.

When was Trial of Anifrolumab in Active Systemic Lupus Erythematosus published?

ScholarIQyear

Trial of Anifrolumab in Active Systemic Lupus Erythematosus has 2019 year in the ScholarIQ index.

What is the open-access status of Trial of Anifrolumab in Active Systemic Lupus Erythematosus?

ScholarIQoa status

Trial of Anifrolumab in Active Systemic Lupus Erythematosus has bronze oa status in the ScholarIQ index.

What is the DOI of Trial of Anifrolumab in Active Systemic Lupus Erythematosus?

ScholarIQdoi

The DOI for Trial of Anifrolumab in Active Systemic Lupus Erythematosus is on the source record.

What is the PMID of Trial of Anifrolumab in Active Systemic Lupus Erythematosus?

ScholarIQpmid

The PMID for Trial of Anifrolumab in Active Systemic Lupus Erythematosus is on the source record.

What is the OpenAlex record for Trial of Anifrolumab in Active Systemic Lupus Erythematosus?

ScholarIQopenalex

The OpenAlex for Trial of Anifrolumab in Active Systemic Lupus Erythematosus is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial